Telix Pharmaceuticals Limited Faces Securities Fraud Class Action Lawsuit

A securities fraud class action lawsuit has been filed against Telix Pharmaceuticals Limited (TLX) on behalf of investors who purchased or acquired TLX securities between February 21, 2025 and August 28, 2025. The lawsuit alleges that defendants made false and/or misleading statements about the company's business, operations, and prospects. Investors who purchased TLX securities during this period may move to request appointment as lead plaintiff by January 9, 2026.